UNSPSC 51141513: Carbamazepine

This classification denotes an anticonvulsant agent with the molecular formula C15H12N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33CM23913M, chemically known as 5h-dibenz(b,f)azepine-5-carboxamide but generally known as carbamazepine, which bears US NIH Compound Identifier 2554. Carbamazepine most often comes in base, dihydrate, epoxide, and glucuronide forms. European Medicines Agency schedules Carbamazepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06113MIG.

UNSPSC 51141513 Carbamazepine is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the single recent opportunity in the dataset does not involve carbamazepine itself. Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB (Invitation for Bid) in mid-2023, indicating that state and local health departments use codes in this pharmaceutical family to source controlled or emergency-response medications and related equipment. The scope of work under this code spans prescription medications, emergency pharmaceuticals, and supporting delivery infrastructure, with vendors required to meet standard compliance requirements including E-Verify authorization, drug-free workplace certification, and appropriate insurance coverage.

Activity under this code centers in Florida based on the available recent opportunity. Seminole County's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract included an initial two-year term with a one-year renewal option and potential FEMA funding, which introduced federal compliance overlay including Clean Air Act and Federal Water Pollution Control Act adherence. Vendors were responsible for all shipping and delivery costs, and the procurement emphasized transparency, record-keeping, and termination rights during an initial three-month probationary period. The dataset provides limited geographic diversity or issuing-body breadth for this code, with no additional recent opportunities supporting broader characterization of state or local carbamazepine purchasing activity.